发明名称 |
Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
摘要 |
The invention relates to methods and compositions for promoting cognitive function and/or treating cognitive function disorders and impairments. In particular the methods are accomplished by administering to a subject CI-994 or dinaline or a pharmaceutically acceptable salt, ester, prodrug or metabolite thereof. |
申请公布号 |
US8841346(B2) |
申请公布日期 |
2014.09.23 |
申请号 |
US201213595048 |
申请日期 |
2012.08.27 |
申请人 |
Massachusetts Institute of Technology;The Broad Institute, Inc.;The General Hospital Corporation |
发明人 |
Tsai Li-Huei;Guan Ji-Song;Haggarty Stephen J.;Holson Edward;Wagner Florence;Graeff Johannes |
分类号 |
A01N37/18;A61K31/16;A61K31/165;A61K31/195;C07C237/42;A61K45/06;A61K31/167 |
主分类号 |
A01N37/18 |
代理机构 |
Wolf, Greenfield & Sacks, P.C. |
代理人 |
Wolf, Greenfield & Sacks, P.C. |
主权项 |
1. A method of treating cognitive function or impairments in a subject in need thereof comprising:
systemically administering to the subject an effective amount of 4-(acetylamino)-N-(2aminophenyl)benzamide (CI-994) or dinaline or a pharmaceutically acceptable salt. |
地址 |
Cambridge MA US |